Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

NCT01340950 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Central Nervous System Diseases
Dementia

Interventions

DRUG: zidovudine-lamivudine-nevirapine
DRUG: tenofovir-lamivudine-efavirenz

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]